• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Verily Plans Digital Ophthalmology Joint Venture with Santen

Share:

February 12, 2020

Verily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen.

The joint venture does not yet have a name but aims to use machine learning and artificial intelligence techniques, as well as connected and integrated medical devices.

Verily is part of Alphabet, the company that owns Google, and already has experience in ophthalmology.

The company had been trying to develop a smart contact lens with Alcon since 2014, but stopped working on the project four years later.

There are few details about the latest project, with the companies saying that it will use microelectronics and “scalable digital technologies”.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The joint venture does have a CEO – Dimitri Azar joined Verily Life Sciences as senior director of ophthalmic innovations in 2017.

Azar is a Distinguished Professor of Ophthalmology and served as the Dean of the University of Illinois College of Medicine from 2011 to 2018.

Before that he was Professor of Ophthalmology at Harvard Medical School from 2003 until 2006 and was a senior scientist at the Schepens Eye Research Institute.

Azar said: “By combining Santen’s expertise and Verily’s advanced technology, our joint venture is well positioned to tackle innovative projects spanning ophthalmic conditions, such as glaucoma and dry eye. We’ll explore ways to use technology not only to diagnose disease, but to improve treatment and develop more precise interventions in ophthalmology.”

Shigeo Taniuchi, president and COO of Santen said: “This joint venture will combine Verily’s cutting-edge digital technology and our global industrial and commercial ophthalmology business platform to pursue innovation in ophthalmology.

“Santen has actively promoted collaboration and open innovation with various external organisations in order to enhance eye health, and corresponding quality of life, for people around the world. Digital technology is a transformational driver in health and we hope that this joint venture will be a significant step forward in paving the way for better eye care around the world.”

Source: Pharmaphorum

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Major Payers Find HHS Finalized Nondiscrimination Rule Too NarrowMajor Payers Find HHS Finalized Nondiscrimination Rule Too Narrow
  • New Clinically Validated Sleepcheck App LaunchesNew Clinically Validated Sleepcheck App Launches
  • Apple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care SectorApple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care Sector
  • Google Moves Further Into Healthcare: a Timeline of the Last YearGoogle Moves Further Into Healthcare: a Timeline of the Last Year
  • Superb Healthcare At Ultra-Low Prices? How Singapore Does ItSuperb Healthcare At Ultra-Low Prices? How Singapore Does It
  • AI, Machine Learning, and Blockchain are Key for Healthcare InnovationAI, Machine Learning, and Blockchain are Key for Healthcare Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications